Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 7.96 USD -0.62%
Market Cap: 168.3m USD

Wall Street
Price Targets

DERM Price Targets Summary
Journey Medical Corp

Wall Street analysts forecast DERM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DERM is 13.77 USD with a low forecast of 12.12 USD and a high forecast of 16.8 USD.

Lowest
Price Target
12.12 USD
52% Upside
Average
Price Target
13.77 USD
73% Upside
Highest
Price Target
16.8 USD
111% Upside
Journey Medical Corp Competitors:
Price Targets
003850
Boryung Corp
34% Upside
DHG
Dhg Pharmaceutical Joint-Stock Co
18% Upside
AVDL
Avadel Pharmaceuticals PLC
0% Downside
002332
Zhejiang Xianju Pharmaceutical Co Ltd
31% Upside
300558
Betta Pharmaceuticals Co Ltd
37% Upside

Revenue
Forecast

Revenue Estimate
Journey Medical Corp

For the last 4 years the compound annual growth rate for Journey Medical Corp's revenue is 6%. The projected CAGR for the next 3 years is 41%.

6%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Journey Medical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Journey Medical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DERM's stock price target?
Price Target
13.77 USD

According to Wall Street analysts, the average 1-year price target for DERM is 13.77 USD with a low forecast of 12.12 USD and a high forecast of 16.8 USD.

What is Journey Medical Corp's Revenue forecast?
Projected CAGR
41%

For the last 4 years the compound annual growth rate for Journey Medical Corp's revenue is 6%. The projected CAGR for the next 3 years is 41%.

Back to Top